Lista de obras - Anita Langerød - Dominio Público Uruguay

AMG 900, pan-Aurora kinase inhibitor, preferentially inhibits the proliferation of breast cancer cell lines with dysfunctional p53.

artículo científico publicado en 2013

Assessment of TP53 Polymorphisms and MDM2 SNP309 in Premenopausal Breast Cancer Risk.

artículo científico publicado en 2016

Association of the germline TP53 R72P and MDM2 SNP309 variants with breast cancer survival in specific breast tumor subgroups

artículo científico publicado en 2011

Author Correction: Landscape of somatic mutations in 560 breast cancer whole-genome sequences

artículo científico publicado en 2019

BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutations

artículo científico publicado en 2010

BUB1infrequently mutated in human breast carcinomas ⬇️

artículo científico publicado el 1 de noviembre de 2003

Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltration

artículo científico publicado en 2016

CAMK1D amplification implicated in epithelial-mesenchymal transition in basal-like breast cancer

artículo científico publicado en 2008

Combining gene signatures improves prediction of breast cancer survival

artículo científico publicado en 2011

Common genetic variation in GATA-binding protein 3 and differential susceptibility to breast cancer by estrogen receptor alpha tumor status

artículo científico publicado en 2007

Common genetic variation in TP53 and its flanking genes, WDR79 and ATP1B2, and susceptibility to breast cancer

artículo científico publicado en 2007

Complex landscapes of somatic rearrangement in human breast cancer genomes

artículo científico publicado en 2009

DNA copy number motifs are strong and independent predictors of survival in breast cancer

artículo científico publicado en 2020

Different gene expression patterns in invasive lobular and ductal carcinomas of the breast

artículo científico publicado en 2004

Direct Transcriptional Consequences of Somatic Mutation in Breast Cancer

scientific article published on 03 August 2016

Discovery and validation of breast cancer subtypes

artículo científico publicado en 2006

Discovery and validation of breast cancer subtypes.

artículo científico publicado en 2007

EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer

artículo científico publicado en 2008

Epithelial-stromal interaction 1 (EPSTI1) substitutes for peritumoral fibroblasts in the tumor microenvironment

artículo científico publicado en 2010

Expression of full-length p53 and its isoform Deltap53 in breast carcinomas in relation to mutation status and clinical parameters

artículo científico publicado en 2006

Expression of wild-type and mutated in breast carcinomas

Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters

artículo científico publicado en 2011

Focal amplification and oncogene dependency of GAB2 in breast cancer

artículo científico publicado en 2009

Full sequencing of TP53 identifies identical mutations within in situ and invasive components in breast cancer suggesting clonal evolution

artículo científico publicado en 2009

Functional characterization of the 19q12 amplicon in grade III breast cancers

artículo científico publicado en 2012

Gene expression profiles and the TP53 mutation status are powerful prognostic markers of breast cancer

artículo científico publicado en 2005

Gene expression profiling of breast cancer in relation to estrogen receptor status and estrogen-metabolizing enzymes: clinical implications.

artículo científico publicado en 2005

Genomic architecture characterizes tumor progression paths and fate in breast cancer patients

artículo científico publicado en 2010

High frequency of skewed X inactivation in young breast cancer patients

artículo científico publicado en 2002

Human papillomavirus DNA and e6/e7 mRNA status in relation to survival of patients treated for cervical squamous cell carcinoma

artículo científico publicado en 2008

Independent prognostic value of somatic TP53 gene mutations in 1794 breast cancer patients.

artículo científico publicado en 2005

Landscape of somatic mutations in 560 breast cancer whole-genome sequences

artículo científico publicado en 2016

Lymphocyte Invasion in IC10/Basal-Like Breast Tumors Is Associated with Wild-Type TP53.

artículo científico publicado en 2014

Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway

artículo científico publicado en 2012

Mutation of GATA3 in human breast tumors

artículo científico publicado en 2004

Mutational processes molding the genomes of 21 breast cancers

artículo científico publicado en 2012

Overexpression of cyclin A overrides the effect of p53 alterations in breast cancer patients with long follow-up time

artículo científico publicado en 2003

Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice

artículo científico publicado en 2017

Somatic mutation databases as tools for molecular epidemiology and molecular pathology of cancer: proposed guidelines for improving data collection, distribution, and integration

artículo científico publicado en 2009

Somatic sequence alterations in twenty-one genes selected by expression profile analysis of breast carcinomas

artículo científico publicado en 2007

Studies of TP53 haplotypes in relation to LOH and TP53 mutations in breast cancer patients

artículo científico publicado en 2000

TP53 Mutations in Breast and Ovarian Cancer

artículo científico publicado en 2016

TP53 mutation spectrum in breast cancer is subtype specific and has distinct prognostic relevance

artículo científico publicado en 2014

TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer

artículo científico publicado en 2007

TP53 mutations among molecular subtypes of HER2-positive tumors.

artículo científico publicado en 2005

The Life History of 21 Breast Cancers

The Longitudinal Transcriptional Response to Neoadjuvant Chemotherapy with and without Bevacizumab in Breast Cancer

artículo científico publicado en 2017

The Sub-Cellular Localization of WRAP53 Has Prognostic Impact in Breast Cancer

artículo científico publicado en 2015

The TP53 codon 72 polymorphism may affect the function of TP53 mutations in breast carcinomas but not in colorectal carcinomas.

artículo científico publicado en 2002

The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer

artículo científico publicado en 2006

The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups ⬇️

artículo científico publicado el 18 de abril de 2012

The landscape of cancer genes and mutational processes in breast cancer

artículo científico publicado en 2012

The life history of 21 breast cancers

artículo científico publicado en 2012

p53 polymorphism and risk of cervical cancer

scientific article published on 01 December 1998

p53-Dependent repression of focal adhesion kinase in response to estradiol in breast cancer cell-lines

artículo científico publicado en 2010

Lista de obras de Anita Langerød

AMG 900, pan-Aurora kinase inhibitor, preferentially inhibits the proliferation of breast cancer cell lines with dysfunctional p53.

Assessment of TP53 Polymorphisms and MDM2 SNP309 in Premenopausal Breast Cancer Risk.

Association of the germline TP53 R72P and MDM2 SNP309 variants with breast cancer survival in specific breast tumor subgroups

Author Correction: Landscape of somatic mutations in 560 breast cancer whole-genome sequences

BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutations

BUB1infrequently mutated in human breast carcinomas ⬇️

Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltration

CAMK1D amplification implicated in epithelial-mesenchymal transition in basal-like breast cancer

Combining gene signatures improves prediction of breast cancer survival

Common genetic variation in GATA-binding protein 3 and differential susceptibility to breast cancer by estrogen receptor alpha tumor status

Common genetic variation in TP53 and its flanking genes, WDR79 and ATP1B2, and susceptibility to breast cancer

Complex landscapes of somatic rearrangement in human breast cancer genomes

DNA copy number motifs are strong and independent predictors of survival in breast cancer

Different gene expression patterns in invasive lobular and ductal carcinomas of the breast

Direct Transcriptional Consequences of Somatic Mutation in Breast Cancer

Discovery and validation of breast cancer subtypes

Discovery and validation of breast cancer subtypes.

EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer

Epithelial-stromal interaction 1 (EPSTI1) substitutes for peritumoral fibroblasts in the tumor microenvironment

Expression of full-length p53 and its isoform Deltap53 in breast carcinomas in relation to mutation status and clinical parameters

Expression of wild-type and mutated in breast carcinomas

Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters

Focal amplification and oncogene dependency of GAB2 in breast cancer

Full sequencing of TP53 identifies identical mutations within in situ and invasive components in breast cancer suggesting clonal evolution

Functional characterization of the 19q12 amplicon in grade III breast cancers

Gene expression profiles and the TP53 mutation status are powerful prognostic markers of breast cancer

Gene expression profiling of breast cancer in relation to estrogen receptor status and estrogen-metabolizing enzymes: clinical implications.

Genomic architecture characterizes tumor progression paths and fate in breast cancer patients

High frequency of skewed X inactivation in young breast cancer patients

Human papillomavirus DNA and e6/e7 mRNA status in relation to survival of patients treated for cervical squamous cell carcinoma

Independent prognostic value of somatic TP53 gene mutations in 1794 breast cancer patients.

Landscape of somatic mutations in 560 breast cancer whole-genome sequences

Lymphocyte Invasion in IC10/Basal-Like Breast Tumors Is Associated with Wild-Type TP53.

Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway

Mutation of GATA3 in human breast tumors

Mutational processes molding the genomes of 21 breast cancers

Overexpression of cyclin A overrides the effect of p53 alterations in breast cancer patients with long follow-up time

Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice

Somatic mutation databases as tools for molecular epidemiology and molecular pathology of cancer: proposed guidelines for improving data collection, distribution, and integration

Somatic sequence alterations in twenty-one genes selected by expression profile analysis of breast carcinomas

Studies of TP53 haplotypes in relation to LOH and TP53 mutations in breast cancer patients

TP53 Mutations in Breast and Ovarian Cancer

TP53 mutation spectrum in breast cancer is subtype specific and has distinct prognostic relevance

TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer

TP53 mutations among molecular subtypes of HER2-positive tumors.

The Life History of 21 Breast Cancers

The Longitudinal Transcriptional Response to Neoadjuvant Chemotherapy with and without Bevacizumab in Breast Cancer

The Sub-Cellular Localization of WRAP53 Has Prognostic Impact in Breast Cancer

The TP53 codon 72 polymorphism may affect the function of TP53 mutations in breast carcinomas but not in colorectal carcinomas.

The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer

The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups ⬇️

The landscape of cancer genes and mutational processes in breast cancer

The life history of 21 breast cancers

p53 polymorphism and risk of cervical cancer

p53-Dependent repression of focal adhesion kinase in response to estradiol in breast cancer cell-lines